Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression
- 18 February 2004
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 92 (2) , 559-567
- https://doi.org/10.1016/j.ygyno.2003.11.011
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Stage at diagnosis of ovarian cancer in the United States, 1992-1997Cancer, 2003
- Discussion: Metastasis and Angiogenesis in Epithelial Ovarian CancerGynecologic Oncology, 2003
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002
- Activated Matrix Metalloproteinase-2—A Potential Marker of Prognosis for Epithelial Ovarian CancerGynecologic Oncology, 2002
- Gelatinase A-Immunoreactive Protein in Ovarian Lesions— Prognostic Value in Epithelial Ovarian CancerGynecologic Oncology, 1999
- Regulation of Matrix Metalloproteinases (MMP-2, -3, -9, and -13) by Interleukin-1 and Interleukin-6 in Mouse Calvaria: Association of MMP Induction with Bone ResorptionEndocrinology, 1998
- Activation of Progelatinase A and Progelatinase A/TIMP-2 Complex by Membrane Type 2-Matrix MetalloproteinaseBiological Chemistry, 1997
- Expression and activity of MMPS and their regulators in ovarian cancerInternational Journal of Cancer, 1994
- The pathogenesis of cancer metastasisNature, 1980